News
All NewsContributorsMoney Matters
Media
All VideosExpert InterviewsMedical World NewsPodcastsCase Based Roundtable SeriesCase of the QuarterEyeViewGrand RoundsInsightsRapid ReadoutViewpointsWhat’s Your WhEYE?
Conferences
Conference CoverageConference Listing
Events
More
Publications
Digital EditionEurope Ophthalmology TimesModern RetinaSupplements and Featured Publications
CME
Partners
Resources
Job BoardSponsored

Subscribe

  • News
    • All News
    • Contributors
    • Money Matters
  • Media
    • Conferences
      • Events
      • Publications
        • CME
        • Partners
        • Subscribe
        • Resources
          • AMD
          • Biosimilars
          • COVID-19
          • Cataract
            • Cataract Surgery
          • Cataract Therapeutics
          • Clinical Diagnosis
            • The Residency Report
            • iOpeners
            • NeuroOp Guru
          • Cornea
          • DME
          • Dry Eye
            • Dry Eye Awareness
          • Gene Therapy
          • Geographic Atrophy
          • IOL
            • IOL Advances
          • Imaging
          • Interventional Glaucoma
            • Glaucoma Awareness
            • Glaucoma Insights
            • Therapeutic Glaucoma
          • OCT
          • Ocular Allergy
          • Ocular Surface Disease
          • Optic Relief
          • Optometry
          • Pediatrics
          • Pharmacy
          • Practice Management
            • Indispensable
          • Presbyopia
          • Ptosis
          • Refractive
            • Refractive Surgery
          • Retina
          • Surgery
          • Technology
          • Therapeutics
          • Understanding Antibiotic Resistance
          • Workplace
          Spotlight -
          Retina
          Advertisement

          Shu-I Yeh, MD, PhD

          Advertisement

          Articles by Shu-I Yeh, MD, PhD

          Novel approaches to treating severe ocular surface and corneal damage

          ByShu-I Yeh, MD, PhD
          July 10th 2023

          Severe ocular surface and corneal damage an unseen public health burden.

          Advertisement

          Latest Updated Articles

          • Novel approaches to treating severe ocular surface and corneal damage
            Novel approaches to treating severe ocular surface and corneal damage

            Published: July 10th 2023 | Updated:



          Advertisement
          Advertisement

          Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

          1

          Lupin signs definitive agreement to acquire VISUfarma

          2

          Vizz officially launches in the United States

          3

          Positive pediatric data emerge from the OPGx-LCA5 phase 1/2 trial of Leber congenital amaurosis type 5

          4

          David Lally discusses the ARCHER trial and the optimistic outcomes fueling future research

          5

          Q&A: Nadia Waheed on the role of OCT in the future of ophthalmology

          • About
          • Advertise
          • Privacy
          • Editorial Info
          • Editorial Board
          • Terms and Conditions
          • Contact Us
          • Do Not Sell My Personal Information
          • Job Board
          Contact Info

          259 Prospect Plains Rd, Bldg H
          Monroe, NJ 08831

          609-716-7777

          • Ophthalmology Times
          • Modern Retina
          • Optometry Times
          • Ophthalmology Times Europe
          EyeCare Network
          Brand Logo

          © 2025 MJH Life Sciences®

          All rights reserved.

          Home
          About Us
          News
          Contact Us